The 92nd China International Pharmaceutical Raw Materials/Intermediates/Packaging/Equipment Trade Fair (API China) successfully concluded in Guangzhou from May 21-23, 2025. As a leading brand event focusing on technological upgrading and innovative development in the pharmaceutical industry, this exhibition brought together over 3,000 pharmaceutical companies and industry elites from around the world, showcasing cutting-edge products and technologies in API production, formulation processing, and medical device manufacturing. It also provided a core platform for companies to interpret policies, exchange technologies, and collaborate on business. Feili Electric showcased its Ozone Sterilizers for Pharmaceutical Industry series and its major new products, gaining widespread recognition from domestic and international customers thanks to its solid technical strength, reliable product quality, and comprehensive service support.
At the exhibition, the Feili sales team consistently greeted every visiting customer with enthusiasm and professionalism. Addressing the core needs of the pharmaceutical industry for Clean Room Ozone Disinfection Machines—such as aseptic control in cleanrooms, sterilization of medical devices, and purification of production water—the team engaged in in-depth communication with both new and existing clients. They patiently answered practical questions regarding equipment selection and compatibility, ozone concentration control, and ongoing maintenance and support, precisely addressing each client's personalized production requirements. Many clients reported on-site that they were already familiar with Feili's technological expertise in ozone disinfection, and this face-to-face interaction further enhanced their appreciation for the stability and compliance of its products. Some existing clients, based on past experiences, directly expressed their intention to collaborate on adding Medical Grade Ozone Systems to their new production lines, fully affirming Feili's professional value.
The core highlight of this exhibition was Feili's newly launched kilogram-level ozone equipment, specifically designed for large-scale production scenarios in the pharmaceutical industry, which immediately attracted significant attention from pharmaceutical companies upon its debut. This product series perfectly meets the practical needs of pharmaceutical production: it supports flexible ozone production rates from 200 to 5000 grams, adaptable to all scenarios from laboratory pilot-scale testing to large-scale production lines; it features a PLC system with an intelligent screen for intuitive operation, supporting multiple working modes including manual, automatic, remote, and power-on modes to meet the control requirements of different production stages; it is equipped with a mobile APP for remote control, allowing customers to monitor key parameters such as equipment operating status, ozone concentration, and operating time in real time, achieving unattended intelligent management; and it features a newly added multi-channel ozone output control design, with each channel independently set with timers and concentration limits, precisely matching the disinfection needs of different areas such as cleanrooms and water treatment workshops, significantly improving production efficiency.
As a national high-tech enterprise integrating design, R&D, production, and sales, Feili has been deeply involved in the ozone field for over 14 years, accumulating more than 40 patented technologies and building a complete solution from raw materials to end products. Addressing the stringent standards of the pharmaceutical industry, Feili's Pharmaceutical Water Ozone Purifier and related products utilize titanium-modified quartz discharge tubes and micro-gap discharge technology, achieving a sterilization efficiency of over 99.9%, leaving no chemical residue, and fully complying with GMP certification requirements. Feili also provides a comprehensive "one-stop" service, including technical support, solution design, equipment matching, system installation, on-site modification, and operation and maintenance, ensuring the smooth implementation and stable operation of customer projects throughout the entire process.
At this exhibition, Feili not only showcased its innovative achievements and corporate strength in Ozone Disinfection for Pharma Production but also accurately grasped industry development trends through in-depth exchanges with global pharmaceutical industry partners. In the future, Feili will continue to focus on "technological innovation" and "superior quality" as its core competitiveness, continuously optimizing its product and service system to provide the global pharmaceutical industry with more cost-effective ozone disinfection solutions, helping pharmaceutical companies achieve efficient, safe, and compliant production upgrades.
